Lisata Therapeutics, Inc.

NasdaqCM:LSTA

Market Cap

USD 23.56 M

Share Price

USD 2.71

Avg Daily Volume

14,125

Change (1 day)

-1.09%

Change (1 year)

-22.13%

Change (YTD)

-9.06%

Lisata Therapeutics, Inc. EBIT Margin for the Trailing 12 Months (TTM) ending December 31, 2024: -2,207.00%

Lisata Therapeutics, Inc. EBIT Margin is -2,207.00% for the Trailing 12 Months (TTM) ending December 31, 2024. EBIT ratio is the ratio of EBIT to revenue, measuring a company's operating profitability without considering non-operating income or expenses.
  • Lisata Therapeutics, Inc. EBIT Margin for the Trailing 12 Months (TTM) ending December 31, 2022 was -47.18%.
Key Data
Date EBIT Margin EBITDA Margin Net Income Margin EBT Margin